According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Novartis commits $7.5 million to the "Blitz the Barriers" campaign, aiming to raise awareness and encourage early testing for ...

Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Over 90% adherence to relugolix in patients with Medicare with prostate cancer for 24 months supports its use as androgen ...